271 related articles for article (PubMed ID: 1191974)
1. Diseases of the central nervous system. Myasthenia gravis.
Havard CW
Br Med J; 1975 Oct; 4(5989):152-4. PubMed ID: 1191974
[No Abstract] [Full Text] [Related]
2. Treatment of myasthenia--I.
Br Med J; 1971 Apr; 2(5754):160-2. PubMed ID: 4325739
[No Abstract] [Full Text] [Related]
3. [Myasthenia gravis pseudoparalytica. Clinical picture, pathogenesis, therapy].
Kunze K
Med Klin; 1973 Jun; 68(22):723-30. PubMed ID: 4715780
[No Abstract] [Full Text] [Related]
4. Treatment of myasthenia. II.
Br Med J; 1971 Apr; 2(5755):213-4. PubMed ID: 5575956
[No Abstract] [Full Text] [Related]
5. [On the therapy of muscular diseases].
Mittelbach F; Bodechtel G
Munch Med Wochenschr; 1968 Sep; 110(36):1988-93. PubMed ID: 5695705
[No Abstract] [Full Text] [Related]
6. [Myasthenia gravis].
Havard CW; Lange MJ
Recenti Prog Med; 1977 Jan; 62(1):9-26. PubMed ID: 323942
[No Abstract] [Full Text] [Related]
7. [Current treatment of myasthenia gravis].
de Assis JL
Rev Paul Med; 1965 Oct; 67(4):231-42. PubMed ID: 5848156
[No Abstract] [Full Text] [Related]
8. Myasthenia gravis and glycopyrrolate.
Marcus E; Wayne F
S Afr Med J; 1981 Oct; 60(17):650. PubMed ID: 7302713
[No Abstract] [Full Text] [Related]
9. The Eaton-Lambert syndrome in ocular myasthenia gravis.
Oh SJ
Arch Neurol; 1974 Sep; 31(3):183-6. PubMed ID: 4855164
[No Abstract] [Full Text] [Related]
10. Pharmacologic enhancement of neuromuscular transmission in myasthenia gravis.
Riggs JE
Clin Neuropharmacol; 1982; 5(3):277-92. PubMed ID: 6288236
[No Abstract] [Full Text] [Related]
11. Progress in myasthenia gravis.
Havard CW
Br Med J; 1973 Aug; 3(5877):437-40. PubMed ID: 4353620
[No Abstract] [Full Text] [Related]
12. Teaching NeuroImages: reversible ectropion in myasthenia gravis.
Solé G; Perez F; Ferrer X
Neurology; 2009 Oct; 73(16):e83. PubMed ID: 19841376
[No Abstract] [Full Text] [Related]
13. [Therapy of pseudoparalytic myasthenia gravis].
Fasshauer K
Dtsch Med Wochenschr; 1975 Oct; 100(44):2283-4. PubMed ID: 1183327
[No Abstract] [Full Text] [Related]
14. Post-varicella myasthenia gravis.
Saha A; Batra P; Vilhekar KY; Chaturvedi P
Singapore Med J; 2007 Jun; 48(6):e177-80. PubMed ID: 17538742
[TBL] [Abstract][Full Text] [Related]
15. The interaction of human cholinesterases with anticholinesterases used in the therapy of myasthenia gravis.
Foldes FF; Smith JC
Ann N Y Acad Sci; 1966 Jan; 135(1):287-301. PubMed ID: 5221345
[No Abstract] [Full Text] [Related]
16. Anticholinesterase abuse in myasthenia gravis.
Munsat TL
J Neurol Sci; 1984 Apr; 64(1):5-10. PubMed ID: 6376715
[No Abstract] [Full Text] [Related]
17. The management of myasthenia gravis.
Drug Ther Bull; 1977 Apr; 15(8):29-32. PubMed ID: 872734
[No Abstract] [Full Text] [Related]
18. Myasthenia gravis, an often overlooked disease in the geriatric group.
Stern FH
J Am Geriatr Soc; 1966 Oct; 14(10):1052-7. PubMed ID: 5924629
[No Abstract] [Full Text] [Related]
19. Current treatment of myasthenia gravis.
Osterman PO
Prog Brain Res; 1990; 84():151-61. PubMed ID: 2267293
[No Abstract] [Full Text] [Related]
20. [Myasthenia gravis. Immunosuppressive treatment].
Horn J
Tidsskr Nor Laegeforen; 1971 Apr; 91(11):821-4. PubMed ID: 4326179
[No Abstract] [Full Text] [Related]
[Next] [New Search]
